Carbapenemase-producing Pseudomonas aeruginosa from central Greece: molecular epidemiology and genetic analysis of

Apostolos Liakopoulos, Angeliki Mavroidi, Efstathios A Katsifas

  • 1Department of Microbiology, University Hospital of Larissa, Larissa, Greece. petinaki@med.uth.gr.

BMC Infectious Diseases
|October 31, 2013
PubMed
Abstract

Insights

Multidrug-resistant Pseudomonas aeruginosa, particularly carbapenem-resistant strains, remains a significant threat in Greek hospitals. Ongoing evolution of resistance mechanisms, including integrons and international clones, necessitates continued surveillance.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Multidrug-resistant Pseudomonas aeruginosa poses a significant challenge in treating hospital-acquired infections.
  • A notable increase in carbapenem-resistant P. aeruginosa infections was observed in Central Greece in 2011.
  • Analysis was needed to understand the epidemiology and resistance mechanisms in this region.

Purpose of the Study:

  • To investigate the prevalence and characteristics of carbapenem-resistant Pseudomonas aeruginosa in Greece.
  • To identify the resistance mechanisms, particularly carbapenemases like Verona integron-encoded metallo-β-lactamase (VIM).
  • To assess the genetic relatedness and clonal dissemination of VIM-producing P. aeruginosa.

Main Methods:

  • Collected 568 P. aeruginosa isolates from inpatients in three Greek hospitals over 8 months in 2011.
  • Characterized 284 carbapenem-resistant isolates using antimicrobial susceptibility testing and β-lactamase analysis.
  • Employed BOX-PCR, multilocus sequence typing (MLST), and eBURST for genetic relatedness and integron mapping.

Main Results:

  • Eighty (14.1%) isolates were identified as VIM producers.
  • MLST revealed high prevalence of international clones ST111 and ST235 among blaVIM-2 and blaVIM-4 positive isolates, respectively.
  • Two novel class I integrons were identified alongside previously known structures, with blaVIM-17 found in a novel ST1457.

Conclusions:

  • VIM-producing P. aeruginosa remains a prevalent multidrug-resistant pathogen in Greece.
  • The study highlights the ongoing spread of VIM-producers within common international clones (ST111, ST235).
  • The emergence of novel integrons and divergent structures indicates continuous evolution of resistance in P. aeruginosa.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
115
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
966
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
88
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
251